ArticleEuropean journal of heart failure2019
Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events.
Article in European journal of heart failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.
- Echocardiographic haemodynamic monitoring in the context of HeartMate 3™ therapy: a systematic review.ESC heart failure · 2024Pooled it
- Haemolytic injury and cardiovascular disease.Nature reviews. Cardiology · 2026Review
- Validation of the Hemodynamic Classification System for Hemodynamic-Related Events in Patients With Durable Left Ventricular Assist Devices.Journal of the American Heart Association · 2025Article
- Fibrosis 4 Index Predicts Haemocompatibility-Related Adverse Events in Patients Using Left Ventricular Assist Devices.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025Article
- Association of Renin-Angiotensin-Aldosterone System Inhibitors With Clinical Outcomes, Hemodynamics, and Myocardial Remodeling Among Patients With Advanced Heart Failure on Left Ventricular Assist Device Support.Journal of the American Heart Association · 2024Article
- Hemodynamic parameters at rest predicting exercise capacity in patients supported with left ventricular assist device.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2024Article
- Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device.International journal of molecular sciences · 2023Review
- The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices.Artificial organs · 2023Article
- The Effect of Age on Non-Invasive Hemodynamics in Chronic Heart Failure Patients on Left-Ventricular Assist Device Support: A Pilot Study.Journal of clinical medicine · 2022Article
- Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study.Artificial organs · 2022Article
- Factors influencing the functional status of aortic valve in ovine models supported by continuous-flow left ventricular assist device.Artificial organs · 2022Article
- Pulmonary Artery Pulsatility Index and Hemolysis during Impella-Incorporated Mechanical Circulatory Support.Journal of clinical medicine · 2022Article
- Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: A comprehensive review.Frontiers in cardiovascular medicine · 2022Review
- Article
- Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipients.ESC heart failure · 2021Article
- Survival after left ventricular assist device implantation correlates with a novel device-based measure of heart rate variability: the heart rate score.Interactive cardiovascular and thoracic surgery · 2021Article
- Reverse Remodeling With Left Ventricular Assist Devices.Circulation research · 2021Review
- Invasive Haemodynamic Assessment Before and After Left Ventricular Assist Device Implantation: A Guide to Current Practice.Interventional cardiology (London, England) · 2021Review
- Novel Acoustic Biomarker of Quality of Life in Left Ventricular Assist Device Recipients.Journal of the American Heart Association · 2021Article
- Advances in Hemodynamic Monitoring in Heart Failure Patients.Internal medicine (Tokyo, Japan) · 2021Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
14 authors at 1 institution in 1 country.
Funding
Abstract
aimsLeft ventricular assist device (LVAD) therapy improves the haemodynamics of advanced heart failure patients. However, it is unknown whether haemodynamic optimization improves haemocompatibility-related adverse events (HRAEs). This study aimed to assess HRAEs in patients with optimized haemodynamics. METHODS AND
resultsEighty-three outpatients [aged 61 (53-67) years, 50 male] underwent a haemodynamic ramp test at 253 (95-652) days after LVAD implantation, and 51 (61%) had optimized haemodynamics (defined as central venous pressure < 12 mmHg, pulmonary artery wedge pressure < 18 mmHg, cardiac index > 2.2 L/min/m
conclusionLeft ventricular assist device patients in whom haemodynamics can be optimized had greater freedom from HRAEs compared to those without optimized haemodynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.